
    
      At present, many studies have shown that DES and DCB are effective means for the treatment of
      Des ISR, and they are also the first-line treatment strategies recommended by the guideline
      [13]. The use of DCB avoids the re implantation of stents, and "intervention without
      implantation". The control device is sequent please, which is widely used in clinic and has
      been approved by clinical experts.

      This is a prospective, multicenter, randomized controlled, non inferiority clinical trial.
      Prospective, multicenter studies were carried out according to a unified protocol to avoid
      bias or confounding factors and ensure the quality of the trial. Randomized controlled
      clinical trial design can provide high-level evidence-based medicine
    
  